Physician profile
David J Vasil
NPI 1245551282
$841.79
in general payments reported to CMS, 2019-2025
10 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2022: $72.00 · 2023: $246 · 2024: $298 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $304.57 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $191.15 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $119.81 | 2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.46 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $47.36 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $41.91 | 2023 | Camzyos, Eliquis |
| Abiomed | $25.94 | 2023 | Impella |
| Irhythm Technologies, INC. | $23.19 | 2022 | |
| Smith+Nephew, INC. | $21.90 | 2024 | Grafix Pl |
| Gilead Sciences, INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Vasil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.